Böckmann M, Drosten M, Pützer BM.
Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma.
Mol Ther. 2004; 9: S236-S236 622 Suppl. 1.
Previous Post
Update on adenoviruses and retargeting.
Next Post
Loss of neoplastic phenotype by specific inhibition of RET oncogene signalling in a transgenic model of primary medullary thyroid carcinoma.